WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000027832) THIAZOLE DERIVATIVES AS PPAR GAMMA LIGANDS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/027832    International Application No.:    PCT/EP1999/008477
Publication Date: 18.05.2000 International Filing Date: 09.11.1999
Chapter 2 Demand Filed:    12.05.2000    
IPC:
A61K 31/426 (2006.01), A61K 31/443 (2006.01), A61K 31/4439 (2006.01), C07D 277/14 (2006.01), G01N 33/566 (2006.01)
Applicants: GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN (GB) (For All Designated States Except US).
COLLINS, Jon, Loren [US/US]; (US) (For US Only).
HOLMES, Christopher, Patrick [US/US]; (US) (For US Only).
LENHARD, James, Martin [US/US]; (US) (For US Only).
WILLSON, Timothy, Mark [GB/US]; (US) (For US Only)
Inventors: COLLINS, Jon, Loren; (US).
HOLMES, Christopher, Patrick; (US).
LENHARD, James, Martin; (US).
WILLSON, Timothy, Mark; (US)
Agent: LEAROYD, Stephanie, Anne; Glaxo Wellcome plc Glaxo Wellcome House Berkeley Avenue Greenford Middlesex UB6 0NN (GB)
Priority Data:
9824614.3 11.11.1998 GB
Title (EN) THIAZOLE DERIVATIVES AS PPAR GAMMA LIGANDS
(FR) LIGANDS DE PPAR GAMMA
Abstract: front page image
(EN)The present invention discloses novel PPARgamma ligands of Formula (I) and pharmaceutically acceptable salts and solvates thereof. The present invention also discloses a method for treating osteoporosis by administration of a PPARgamma antagonist. n=2 - 4 and R¿1? - R¿5? are as in the application.
(FR)Nouveaux ligands PPARgamma (récepteurs activés par le proliférateur de péroxysome) de formule (I) et sels et solvats pharmaceutiquement acceptables desdits ligands. La présente invention concerne également une méthode de traitement de l'ostéoporose par administration d'un antagoniste de PPARgamma.
Designated States: AE, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)